#News #USA #InsideTrading
How many are profiting from this???
On Wall Street, Moderna dropped 5.8% after saying the U.S. Food and Drug Administration is refusing to consider its application for a new flu vaccine made with Nobel Prize-winning mRNA technology. It’s the latest sign of the FDA’s heightened scrutiny of vaccines under Health Secretary Robert F. Kennedy Jr.





